Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information , 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE (DD-MM-YYYY)
31-07-2008
REPORT TYPE
Annual
DATES COVERED (From -To
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) AND ADDRESS(ES)
PERFORMING ORGANIZATION REPORT NUMBERUniversity of Pittsburgh Office of Research 350 Thackeray Hall Pittsburgh, PA 15260
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S)
US Army Medical Research And Materiel Command Fort Detrick, MD 21702-5104
SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENTApproved for public release; distribution unlimited
SUPPLEMENTARY NOTES
ABSTRACTDuring the last year of support (from July 1, 2007 to June 30, 2008, our studies have made significant progresses in all aspects of the study: i) we demonstrate that PTH increases ATF4 expression and activity and ATF4 is required for PTH induction of Ocn expression in osteoblasts. ATF4 is a novel downstream target of PTH signaling in osteoblasts; ii) we show that ATF4 is required for the anabolic actions of PTH on bone in vivo, these results were orally presented at the 2007 ASBMR (American Society for Bone and Mineral Research) annual meeting; and iii) We also shows that TFIIAγ increases osteoblast-specific gene expression by facilitating ATF4-Runx2 interactions; Taken together, these data further strongly support our original hypothesis and the specific aims. Two peer-reviewed research papers and two national meeting abstracts are generated from this study during this period of support. In the next year of support, we will: i) determine if ATF4 is required for the anabolic actions of PTH on bone in greater detail; ii) determine if ATF4 is required for PTH regulations of cell proliferation and apoptosis in vitro and in vivo; and iii) determine the role of ATF4-Runx2 interactions in PTH-induced osteoblast function. This progress report covers research from the period 04/01/07-06/30/08
SUBJECT TERMS
IntroductionOsteoporosis is a bone disease that affects a large numbers of both men and women including many of our service women and men now in the Armed Forces and VA patients in the United States. It causes a significant amount of morbidity and mortality in patients and is often dia...